What question did this study set out to answer?

To review the prognostic role of admission hyperglycaemia in acute coronary syndromes beyond baseline diabetes and evaluate whether intensive insulin therapy improves patient outcomes.

August 12, 2008Heart

Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?

View Full Paper

Ask AI

Bookmark

Why the study?

Does intensive insulin treatment improve outcomes in patients with acute coronary syndrome and hyperglycaemia?

Population

Patients with acute coronary syndrome (ACS) / acute myocardial infarction (AMI)

Design

Review

Authors

RAR. AnantharamanKasturba Medical College Hospital MHMartyn HeatleySwansea Bay University Health Board CWClive WestonGeneral Cardiology

Discussion

Member takes

Implication

Hyperglycaemia marks higher ACS mortality risk; leaves open whether intensive insulin therapy improves outcomes.

Key Points

To review the prognostic role of admission hyperglycaemia in acute coronary syndromes beyond baseline diabetes and evaluate whether intensive insulin therapy improves patient outcomes.
Reviewed clinical evidence connecting elevated admission blood glucose with adverse outcomes in acute coronary syndrome (ACS) and acute myocardial infarction (AMI).
Analyzed biological mechanisms linking acute hyperglycaemia to worsened myocardial tissue damage.
Evaluated clinical trials assessing intensive insulin interventions for rapid glucose normalization.
Elevated admission blood glucose strongly correlates with poorer prognosis and increased mortality in acute coronary syndrome, reflecting mechanisms beyond pre-existing diabetic status.
Acute hyperglycaemia directly contributes to adverse pathophysiological processes during acute myocardial infarction.
Interventions employing intensive insulin therapy to rapidly normalize glucose levels demonstrate inconsistent clinical benefits and uncertain utility.

Structured PICO

Does intensive insulin treatment improve outcomes in patients with acute coronary syndrome and hyperglycaemia?

Population

Patients with acute coronary syndrome (ACS) / acute myocardial infarction (AMI)

Intervention

Intensive insulin treatment

Outcome

Clinical outcome/prognosis

This review discusses the prognostic significance of hyperglycaemia in ACS and evaluates the evidence for intensive insulin therapy.

Cite This Study

Anantharaman et al. (2008) studied this question.

synapsesocial.com/papers/6a767281ed4768d249c44581 https://doi.org/10.1136/hrt.2008.146027

View Full Paper

Ask AI

Bookmark

Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider